The company has used full-stack solutions to advance brake-by-wire technology, helping move the sector from initial adoption toward more sophisticated products. Based on brake-by-wire solution sales in 2025, Nasn ranked among China’s three largest domestically owned brake-by-wire solution providers and was the country’s second largest domestically owned independent third-party provider of such solutions. Qiming Venture Partners co-led the company’s Series A funding round in 2018 and continued to support it in its Series B round. Using the Attobody platform, Attovia has nominated three product candidates: ATTO-1310, ATTO-2306, and ATTO-1091. “The differentiated Attobody technology platform licensed by Attovia from Alamar provides a powerful tool for developing complex multispecific biologics.